Balyasny Asset Management’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-140,492
| Closed | -$24.2M | – | 2472 |
|
|
2021
Q3 | $24.2M | Buy |
+140,492
| New | +$24.2M | 0.1% | 247 |
|
|
2018
Q4 | – | Sell |
-7,476
| Closed | -$428K | – | 1677 |
|
|
2018
Q3 | $428K | Sell |
7,476
-715
| -9% | -$40.9K | ﹤0.01% | 1199 |
|
|
2018
Q2 | $397K | Buy |
+8,191
| New | +$397K | ﹤0.01% | 1244 |
|
|
2018
Q1 | – | Sell |
-58,500
| Closed | -$2.48M | – | 2140 |
|
|
2017
Q4 | $2.48M | Buy |
+58,500
| New | +$2.48M | 0.01% | 868 |
|